TransMedics Group, Inc.
(NASDAQ: TMDX)

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

138.835 -

-2.155 (-1.53%)
Range 137.030 - 144.800   (5.67%)
Open 143.590
Previous Close 140.990
Bid Price 138.760
Bid Volume 1
Ask Price 139.070
Ask Volume 128
Volume 362,692
Value 37,446,349
Remark -
Delayed prices. Updated at 30 Jan 2026 01:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis